Back to Results
First PageMeta Content



What is CAPRISA 004? CAPRISA 004 was a phase IIb, two-arm, double-blind, randomised, placebo-controlled trial designed to assess the safety and effectiveness of the vaginal microbicide candidate 1% tenofovir gel for the
Add to Reading List

Document Date: 2010-07-06 15:54:36


Open Document

File Size: 136,20 KB

Share Result on Facebook